Rate-responsive pacing in patients with heart failure: Long-term results of a randomized study

Europace

Volumn 10, Issue 10, 2008, Pages 1182-1188

  Nägele, Herbert ^a   Rödiger, Wilfried ^b   Castel, Maria Angeles ^c  

^a Medical Department   (Germany)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Atrioventricular delay; Heart failure; Heart rate; Rate adaptive pacing

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BISOPROLOL; CARVEDILOL; DIGITALIS GLYCOSIDE; DIGITOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL; SPIRONOLACTONE; VASODILATOR AGENT; XIPAMIDE;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLURRED VISION; CARDIOVASCULAR PARAMETERS; CHRONOTROPISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL DISEASE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART STIMULATION; HEART VENTRICLE PACING; HUMAN; HYPERTHYROIDISM; LONG TERM CARE; LOW DRUG DOSE; LUNG FIBROSIS; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; COMORBIDITY; FEMALE; GERMANY; HEART FAILURE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 52949152820     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun213     Document Type: Article

References (34)

1. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006;114:2138-47.
2. Jorde UP, Vittorio TJ, Kasper ME, Arezzi E, Colombo PC, Goldsmith RL et al. Chronotropic incompetence, beta-blockers, and functional capacity in advanced congestive heart failure: time to pace? Eur J Heart Fail 2008;10:96-101.
3. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982;307:205-11.
4. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 1986;74:1290-302.
5. White M, Yanowitz F, Gilbert EM, Larrabee P, O'Connell JB, Anderson JL et al. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 1995;76:1271-6.
6. Luu M, Stevenson WG, Stevenson LW, Baron W, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989;80:1675-80.
7. Nägele H, Bohlmann M, Eck U, Petersen B, Rödiger W. Combination therapy with carvedilol and amiodarone in patients with severe heart failure. Eur J Heart Fail 2000;2:71-9.
8. Auricchio A, Sommariva L, Salo RW, Scafuri A, Chiariello L. Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay. Pacing Clin Electrophysiol 1993;16:2034-43.
9. Brecker SJ, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing with atrioventricular delay in dilated cardiomyopathy. Lancet 1992;340:1308-12.
10. Nägele H, Schomburg R, Petersen B, Rödiger W. Dual chamber pacing in patients with severe heart failure on beta blocker and amiodarone treatment: preliminary results of a randomised study. Heart 2002;87:566-7.
11. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;344:493-8.
12. Jensen DG, Genter F, Froelicher VF, Kearney J, Ashburn W. Individual variability of radionuclide ventriculography in stable coronary artery disease patients over one year. Cardiology 1984;71:255-65.
13. Palatini P. Heart rate as a cardiovascular risk factor. Eur Heart J 1999;Suppl. 1:B3-9.
14. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1991;121:172-7.
15. Levine HJ. Rest heart rate and life expectancy. J Am Coll Cardiol 1997;30:1104-6.
16. Spinale F. Pathophysiology of Tachycardia-induced Heart Failure. Armonk, NY: Futura; 1996. p1-231.
17. Heilbrunn SM, Shah P, Bristow MR, Valentine HA, Ginsburg R, Fowler MB. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989;79:483-90.
18. Nagatsu M, Spinale FG, Koide M, Tagawa H, DeFreitas G, Cooper G IV et al. Bradycardia and the role of β-blockade in the amelioration of left ventricular dysfunction. Circulation 2000;101:653-9.
19. Moe GW, Grima EA, Howard RJ, Seth R, Armstrong PW. Left ventricular remodelling and disparate changes in contractility and relaxation during the development of and recovery from experimental heart failure. Cardiovasc Res 1994;28:66-71.
20. Zhang J, Toher C, Erhard M, Zhang Y, Ugurbil K, Bache RJ et al. Relationships between myocardial bioenergetic and left ventricular function in hearts with volume-overload hypertrophy. Circulation 1997;96:334- 43.
21. Pai RG, Buech GC. Newer Doppler measures of left ventricular diastolic function. Clin Cardiol 1996;19:277-88.
22. Lamas GA, Knight DJ, Sweeney MO, Mianulli M, Jorapur V, Khalighi K et al. Impact of rate modulated pacing on quality of life and exercise capacity: evidence from the advanced elements of pacing randomized controlled trial (ADEPT). Heart Rhythm 2007;4:1125-32.
23. Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez-Sendon JL et al., for the Heart Rate Working Group. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007;50:823-30.
24. Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F et al. Long-term heart rate reduction induced by the selective If current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004;109:1674- 9.
25. Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001;103:1428-33.
26. Lee MA, Dae MW, Langberg JJ, Griffin JC, Chin MC, Finkbeiner WE et al. Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology. J Am Coll Cardiol 1994;24:225-32.
27. Rosenqvist M, Isaaz K, Botvinick EH, Dae MW, Cockrell J, Abbott JA et al. Relative importance of activation sequence compared to atrioventricular synchrony in left ventricular function. Am J Cardiol 1991;67:148- 56.
28. Saxon LA, Kerwin WF, Cahalan MK, Kalman JM, Olgin JE, Foster E et al. Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation/contraction sequence in patients with depressed ventricular function. J Cardiovasc Electrophysiol 1998;9:13-21.
29. Karpawich PP, Justice CD, Cavitt DL, Chang CH. Developmental sequelae of fixed-rate ventricular pacing in the immature canine heart: an electrophysiologic, hemodynamic and histopathologic evaluation. Am Heart J 1990;119:1077-83.
30. Tse HF, Lau CP. Long-term effect of right ventricular pacing on myocardial perfusion and function. J Am Coll Cardiol 1997;29:744- 9.
31. Tantengco MV, Thomas RL, Karpawich PP. Left ventricular dysfunction after long-term right ventricular apical pacing in the young. J Am Coll Cardiol 2001;37:2093-100.
32. Gold MR, Feliciano Z, Gottlieb SS, Fisher ML. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol 1995;26:967-73.
33. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H et al., Dual Chamber VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. J Am Med Assoc 2002;288:3115-23.
34. Hayes JJ, Sharma AD, Love JC, Herre JM, Leonen AO, Kudenchuk PJ, DAVID Investigators. Abnormal conduction increases risk of adverse outcomes from right ventricular pacing. J Am Coll Cardiol 2006;48:1628-33.